Literature DB >> 11653055

The incommensurability of research risks and benefits: practical help for research ethics committees.

Douglas K Martin, Eric M Meslin, Nitsa Kohut, Peter A Singer.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1995        PMID： 11653055

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  5 in total

1.  The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.

Authors:  H E M van Luijn; N K Aaronson; R B Keus; A W Musschenga
Journal:  J Med Ethics       Date:  2006-03       Impact factor: 2.903

2.  The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research.

Authors:  David B Resnik
Journal:  Account Res       Date:  2016-06-13       Impact factor: 2.622

3.  Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.

Authors:  Jeremy Sugarman; Randy Stalter; Kevin Bokoch; Ting-Yuan Liu; Deborah Donnell
Journal:  IRB       Date:  2015 Jan-Feb

Review 4.  Should living donor liver transplantation be an option when deceased donation is not?

Authors:  Sarah R Lieber; Thomas D Schiano; Rosamond Rhodes
Journal:  J Hepatol       Date:  2017-11-01       Impact factor: 30.083

5.  Too much medicine? Scientific and ethical issues from a comparison between two conflicting paradigms.

Authors:  Francesco Attena
Journal:  BMC Public Health       Date:  2019-01-22       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.